Infinium Pharmachem Limited IPO
Infinium Pharmachem Limited is an NSE SME IPO listed on the NSE SME platform, priced at ₹135 per share. The stock debuted at ₹141.5, delivering a listing gain of 4.8%. The IPO had a lot size of ₹1000 shares and a minimum investment of ₹1,35,000.
Infinium Pharmachem Limited IPO
- IPO Dates
- Mar 31, 2023 – Apr 5, 2023
- Price band
- ₹135 per equity share
- Minimum Investment
- ₹1,35,000
- Issue size
- 1,875,000 shares(aggregating up to ₹25.31 Cr)
- Lot size
- 1000
- Allotment Date
- Apr 11, 2023
- Listing
- Apr 17, 2023
- Listing At
- NSE SME
IPO timeline
-
Mar 31, 2023
Open Date
Completed
-
Apr 5, 2023
Close Date
Completed
-
Apr 11, 2023
Allotment Date
Completed
-
Apr 17, 2023
Listing Date
Completed
Infinium Pharmachem Limited IPO Subscription Details
Infinium Pharmachem Limited IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Infinium Pharmachem Limited IPO Essentials
Infinium Pharmachem Limited IPO Details
Infinium Pharmachem Limited IPO is priced at ₹135 per share with a total issue size of 1,875,000 shares(aggregating up to ₹25.31 Cr). The IPO has a lot size of 1000 shares and is listed on NSE SME.
- Issue price
- ₹135 per equity share
- Lot size
- 1000 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 1,875,000 shares(aggregating up to ₹25.31 Cr)
- Listing at
- NSE SME
- List price
- 141.5
- Listing date
- Registrar
- Bigshare Services Pvt Ltd
- Lead manager
-
Swastika Investmart Ltd
Infinium Pharmachem Limited IPO Analytics
Infinium Pharmachem Limited IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Infinium Pharmachem Limited IPO Subscription Status
Infinium Pharmachem Limited IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 870,000 | 870,000 | 1,740,000 |
|
Day 1
31-03-23 06:00 PM
|
(0.06) x | 0.10 x | 0.10 x |
|
Day 2
03-04-23 06:00 PM
|
(0.33) x | 0.60 x | 0.46 x |
|
Day 3
05-04-23 06:00 PM
|
(1.80) x | 1.86 x | 1.84 x |
Infinium Pharmachem Limited Valuations
Earnings
- EPS (Post IPO)
- ₹60.07/-
Returns
- RoNW
- 43.85%
Infinium Pharmachem Limited Financials( In Lakhs)
| 30-Sept-22 | 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
|---|---|---|---|---|
| Assets | 7,075.71 | 5,899.95 | 3,418.27 | 2,244.60 |
| Revenue | 7,985.39 | 10,005.25 | 7,115.37 | 3,941.64 |
| Profit After Tax | 551.01 | 610.64 | 272.48 | 93.40 |
Infinium Pharmachem Limited Company & Offer Insights
About Infinium Pharmachem Limited
Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
Infinium Pharmachem Limited Promoter(s)
Mr. Sanjaykumar Viththalbhai Patel, r. Pravin Bhadabhai Madhani, Mr. Mitesh Lavjibhai Chikhaliya are the company's promoters of Infinium Pharmachem Limited.
Infinium Pharmachem Limited IPO Issue Objectives
- •
- Marketing and branding expenses (including registration in reach - Europe, and other marketing expenses).
- •
- Repayment of some of the existing loans and expansion of units.
- •
- To meet incremental working capital requirements.
- •
- To meet public issue expenses.
Contact Information
Frequently Asked Questions
Click any question to reveal the answer
Infinium Pharmachem Limited IPO is a Fixed Priced IPO worth ₹1,875,000 shares(aggregating up to ₹25.31 Cr). The issue price is ₹135 per share (fixed price). The IPO opens on Mar 31, 2023 and closes on Apr 5, 2023. It will be listed on NSE SME Platform. Bigshare Services Pvt Ltd is the registrar.
The issue price of Infinium Pharmachem Limited IPO is ₹135 per share (fixed price).
The lot size of Infinium Pharmachem Limited IPO is 1000 shares.
The minimum investment for Infinium Pharmachem Limited IPO is approximately ₹1,35,000 based on the issue price .
Infinium Pharmachem Limited IPO opens on Mar 31, 2023 and closes on Apr 5, 2023.
The allotment date of Infinium Pharmachem Limited IPO is Apr 11, 2023.
Infinium Pharmachem Limited IPO is expected to be listed on Apr 17, 2023, on NSE SME Platform.
Infinium Pharmachem Limited IPO valuation snapshot: P/E N/A, EPS ₹60.07/-, P/B N/A, RoNW 43.85%, and market cap N/A.
To apply for Infinium Pharmachem Limited IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Infinium Pharmachem Limited IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Infinium Pharmachem Limited IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Infinium Pharmachem Limited IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Infinium Pharmachem Limited IPO allotment status on IPO Ji for quick and easy access.